Other Clinical Trial - Evaluate the Efficacy & Safety of Pasireotide LAR

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06163261` - Individualized Physical Activity or Patients With Non Functioning Pituitary Adenoma	N/A
Not yet recruiting	`NCT05005715` - Effect of Dexmedetomidine on Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Surgery	Phase 2
Active, not recruiting	`NCT04218721` - Implementing eHealth Interventions Into Regular Clinical Practice	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT06163261 - Individualized Physical Activity or Patients With Non Functioning Pituitary Adenoma

N/A

Not yet recruiting

NCT05005715 - Effect of Dexmedetomidine on Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Surgery

Phase 2

Active, not recruiting

NCT04218721 - Implementing eHealth Interventions Into Regular Clinical Practice

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01283542
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 2
Start date	November 26, 2012
Completion date	September 12, 2017

Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma. — Passion I

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms